Can ketamine help chronic low back pain?

It depends heavily on what kind of back pain you have. Ketamine acts on the NMDA receptor and central sensitization, so it makes the most sense for back pain with a strong neuropathic or centrally-sensitized character, such as pain that persists long after any injury has healed. For mechanical or structural back pain, it is not a logical fit. The research is mixed and mostly focused on neuropathic pain broadly rather than low back pain specifically, so we look closely at the type of pain before considering it.

What is the difference between mechanical and neuropathic back pain?

Mechanical back pain comes from structures like discs, joints, and muscles and typically tracks with movement and position. Neuropathic back pain comes from the nerves and central nervous system themselves; it can feel burning, electric, or radiating, and it often continues after tissue has healed because the pain-processing system has become sensitized. Ketamine is aimed at that second category. Sorting out which one you have is the first step, and it usually takes a proper pain evaluation.

Does the research support ketamine for low back pain?

The evidence is genuinely mixed. A systematic review of ketamine in neuropathic pain found benefit for neuropathic conditions overall, with some analyses suggesting effects can persist for months after treatment. But a randomized trial of short-term perioperative ketamine in patients undergoing major back surgery found no analgesic benefit. So ketamine has a reasonable case in chronic neuropathic pain broadly and a weaker, less certain one in low back pain specifically. We are upfront that this is not a settled area.

Can ketamine help me reduce opioids for back pain?

One of the more consistent findings in the pain literature is that ketamine can reduce opioid requirements, and some cohort studies have used low-dose ketamine to help people taper opioids in chronic non-cancer pain. That is a meaningful potential role, but it is a medical process that has to be coordinated carefully with the prescriber managing your pain, not something to attempt independently. If reducing opioid reliance is a goal, it is worth raising during an evaluation.

Is ketamine a cure for chronic back pain?

No. Even in the neuropathic pain where ketamine has its best case, the relief is often partial and can be temporary, though some studies suggest longer effects for certain patients. We think of ketamine for the right kind of back pain as a way to interrupt a sensitization cycle and create a window for rehabilitation and other therapies, not as a standalone cure. Setting that expectation honestly is part of how we do this.

Ketamine for Chronic Low Back Pain

Almost everyone deals with back pain at some point, and for a lot of people it never fully leaves. Chronic low back pain is among the leading causes of disability worldwide, and it drives an enormous share of opioid prescriptions—which is part of why people keep asking whether ketamine might offer another route. It’s a fair question, and it has a more specific answer than most marketing gives it.

The honest version starts with a distinction that a lot of pain treatment skips over: what is actually generating your pain? Because ketamine only makes sense for one kind of back pain, and getting that wrong wastes time and money.

Two Very Different Kinds of Back Pain

Broadly, chronic low back pain falls into two camps, and many people have a mix.

Mechanical or structural pain comes from the physical parts of the back—discs, facet joints, muscles, ligaments. It usually tracks with movement and position: worse when you bend or sit, better when you shift or rest. This is the territory of physical therapy, targeted injections, and sometimes surgery. Ketamine has no obvious role here, because there’s an ongoing mechanical driver to address.

Neuropathic and centrally-sensitized pain is different. It comes from the nerves and the central nervous system itself. It can feel burning, electric, or radiating, and—this is the key part—it often continues long after any injury has healed, because the pain-processing system has become sensitized and keeps firing on its own. This is the category where ketamine’s mechanism actually lines up.

We go deeper into that second phenomenon in ketamine and central sensitization, and it’s the same thread that connects difficult back pain to conditions like CRPS, fibromyalgia, and neuropathic pain generally.

Why Ketamine Fits the Neuropathic Kind

Central sensitization runs partly on the NMDA receptor, which sits on nerve cells and helps amplify pain signaling when pain circuits fire over and over. Pain researchers call that amplification “wind-up.” Once it takes hold, the nervous system treats mild input as painful and keeps pain alive after its original cause is gone.

Ketamine is an NMDA-receptor antagonist—it turns that receptor down. That’s why it behaves so differently from opioids in chronic neuropathic pain: instead of muffling a signal, it acts on the machinery that produces and sustains the amplified signal. Our explainer on how ketamine works covers the glutamate side of this in more detail. For back pain, the practical upshot is that ketamine has a real rationale when the pain has gone neuropathic and central, and essentially none when it hasn’t.

What the Research Actually Shows

This is where we’d rather give you the mixed picture than a clean sales pitch, because the mixed picture is the truth.

On the encouraging side, a systematic review and meta-analysis of ketamine in neuropathic pain found benefit across neuropathic conditions, and some analyses suggested that helpful effects could persist for months after treatment ended. That fits ketamine’s broader story: it’s not just an in-the-moment analgesic, and for the right kind of pain it may buy a longer window of relief.

On the cautionary side, a randomized, placebo-controlled trial looked at short-term perioperative ketamine in patients undergoing major lower back surgery, a group with a high prevalence of neuropathic back pain. It found no analgesic benefit from that short infusion added to standard multimodal pain control.

A short-term perioperative ketamine infusion, added to multimodal analgesia in patients undergoing major back surgery, produced no analgesic benefit despite a high prevalence of neuropathic low back pain. — Summarized from a randomized, placebo-controlled trial of perioperative low-dose ketamine

Put those together and the reasonable conclusion is nuanced: ketamine has a decent case in chronic neuropathic pain as a category, and a weaker, less certain case in low back pain specifically—especially in the brief, surgical context that trial studied. The setting, the dosing, and the type of pain all matter, and low back pain hasn’t been the star of the research the way CRPS or phantom pain have. We think that honesty is more useful to you than a confident claim the evidence doesn’t back.

The Opioid Question

There’s one thread worth pulling out on its own. One of the more consistent findings across pain medicine is that ketamine can reduce opioid requirements, and some cohort studies have used low-dose ketamine to help people taper opioids in chronic non-cancer pain. For back pain specifically—a condition tangled up with long-term opioid use for decades—that’s a meaningful potential role.

It’s also a medical process, not a shortcut. Any opioid taper has to be coordinated carefully with the clinician managing your pain, and ketamine would be one part of a larger plan rather than a switch you flip. If getting off or reducing opioids is one of your goals, it’s worth naming that directly during an evaluation. You can read our take on the broader comparison in ketamine for chronic pain vs opioids.

How We’d Think About It

The first job isn’t ketamine—it’s figuring out what kind of back pain you have. A trial of monitored intravenous ketamine is a reasonable thing to consider when the pain has a clear neuropathic, centrally-sensitized character and has resisted the usual approaches: physical therapy, appropriate injections, and standard neuropathic medications like gabapentin or duloxetine. It’s not a first move, and it’s not a fit for straightforward mechanical pain.

A careful evaluation looks at:

The character of your pain—burning and radiating versus movement-linked and mechanical—and what has and hasn’t helped.
Your imaging and diagnosis, and whether structural causes have been addressed by the right specialists.
Your full medication list, since chronic pain patients are often on several drugs and interactions matter.
Blood pressure and cardiovascular status, because ketamine can transiently raise both during an infusion.
Realistic goals—usually interrupting a sensitization cycle and opening a window for rehabilitation, rather than expecting a single course to erase the pain.

The experience of an infusion matters too, especially for someone worn down by years of pain. Our sessions are unhurried and closely attended—Marla stays present throughout—and our therapy dogs, Walter White and Wilma, are part of the calm of the room. Using the days after each session well, with gentle movement and supported follow-up, tends to matter as much as the infusion itself. You can read our overview of candidacy and safety in is ketamine therapy safe, and more about our approach on our chronic pain page.

An Honest Bottom Line

Chronic low back pain is common, stubborn, and heavily entangled with opioids, so the interest in ketamine is understandable. The real answer is conditional: ketamine has a genuine rationale and reasonable evidence for neuropathic, centrally-sensitized pain, a possible role in reducing opioid reliance, and a weaker, less certain track record in low back pain specifically. It offers nothing for mechanical pain. So the useful first step isn’t deciding on ketamine—it’s understanding what’s actually generating your pain. If it turns out to be the sensitized kind that keeps outliving its cause, we’d be glad to talk honestly about whether ketamine belongs in your plan.